top of page
Search
James Pearson
Nov 18, 2024
Optiscan teams up with Minnesota Uni to enter pet market
With 12 million pets diagnosed with cancer annually, Optiscan (ASX: OIL) and the University of Minnesota Veterinary faculty have inked a...
James Pearson
Nov 4, 2024
Optiscan, Monash to develop universal bowel cancer imaging tech
ASX-listed medical technology company Optiscan Imaging (ASX: OIL) has locked in a partnership deal with Monash University to help...
Mark Story
Oct 31, 2024
Optiscan doubles revenue, boosts profit for Sep qtr
Innovative medical device company Optiscan Imaging (ASX: OIL) doubled revenues and tabled its first significant quarterly cash profit...
Andrew Todd
Oct 29, 2024
Optiscan Imaging roadshows cancer detecting imaging devices in US
ASX-listed medical device company Optiscan Imaging (ASX: OIL) has ramped-up its efforts to capture the lucrative US healthcare market by...
James Pearson
Aug 19, 2024
Optiscan Imaging joins US vet school to trial cancer imaging on pets
Optiscan Imaging (ASX: OIL) is moving into veterinary medicine through a memorandum of understanding (MoU) with the United States-based...
Andrew Todd
Jul 29, 2024
Telepathology milestone as Optiscan gets set for commerciality
Optiscan Imaging (ASX: OIL) has developed a cloud-based platform for the remote diagnosis of cancer using its remarkable medical imaging...
Craig Nolan
Jul 15, 2024
Optiscan gets nod for in-surgery breast cancer imaging
Optiscan Imaging (ASX: OIL) has received the nod of approval from the Royal Melbourne Hospital to start taking real-time in-human images...
Matt Birney
Jun 6, 2024
ASX: OIL - Optiscan Imaging
No more biopsies? – a serious revolution in medical science
Michael Philipps
Jun 5, 2024
New Optiscan tech opens door to precision surgery market
ASX-listed Optiscan Imaging (ASX: OIL) has unveiled its latest next-generation microscopic medical imaging device, with its new “InVue”...
Sheena Francis
May 24, 2024
Hoof on the till: Peters backs Optiscan med-tech
Bob Peters is used to backing winners – in fact he has bred and owned a great many of them on his way to becoming the king of WA horse...
Craig Nolan
May 13, 2024
Optiscan extends robotic arm with US medical imaging deal
Optiscan and US-based Mayo Clinic have taken a joint step into the world of robotics in a bid to co-develop digital laser technology for use
Doug Bright
May 2, 2024
Optiscan sees financial green shoots with medical devices
Optiscan Imaging (ASX: OIL) says its latest financial results are just the tip of the iceberg, confident a stronger staff presence in the...
Craig Nolan
Apr 3, 2024
Optiscan sets up shop in US biotech hub
Medical device manufacturer Optiscan Imaging (ASX: OIL) has expanded its U.S push, opening an office in the biotech hub of Minnesota with...
Doug Bright
Mar 21, 2024
Optiscan to power innovative imaging research with tax cash
Optiscan Imaging’s (ASX: OIL) ongoing studies aimed at producing revolutionary medical imaging devices have received a timely financial...
Sheena Francis
Feb 13, 2024
Optiscan looks to AI future with $3m grant
Optiscan Imaging is investigating how it can use AI in the cancer-fighting technology it believes could help create a...
Michael Philipps
Jan 31, 2024
Optiscan more than doubles cash receipts to end 2023
Optiscan Imaging has more than doubled its receipts from customers during the December quarter compared to the previous three-month...
Doug Bright
Nov 30, 2023
Revenue leap for Optiscan as cancer fight continues
A money trail is forming behind Optiscan Imaging’s technology-based mission to tackle the scourge of cancer, with revenue starting to...
Doug Bright
Oct 12, 2023
Optiscan Imaging moves to stamp stronger US footprint
Optiscan Imaging has strengthened its mission aimed at breaking into the United States health market with its “ViewnVivo” technology by...
Doug Bright
Sep 19, 2023
Optiscan on cusp of real-time cancer imaging breakthrough
Optiscan Imaging is on a mission to prove its groundbreaking technology can provide surgeons with the exact extent of breast cancer...
Helen Barling
Sep 1, 2023
Nod of approval: Optiscan deal boosts revenue by 66 per cent
Optiscan Imaging has rounded out a dynamic year with a whopping 66 per cent revenue boost to nearly $1.7 million following the sale of...
bottom of page